|
|
|
Volumn 28, Issue 7, 2005, Pages 224-227
|
|
Rasagiline: A new monoaminoxidase B inhibitor for the treatment of Parkinson's disease;Rasagilin: Neuer monoaminoxidase-B-hemmer zur Parkinson-therapie
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADRENERGIC RECEPTOR STIMULATING AGENT;
ANTIDEPRESSANT AGENT;
CIPROFLOXACIN;
DOPA DECARBOXYLASE INHIBITOR;
ENTACAPONE;
FLUOXETINE;
FLUVOXAMINE;
LEVODOPA;
MONOAMINE OXIDASE INHIBITOR;
PETHIDINE;
RASAGILINE;
SELEGILINE;
ANOREXIA;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG METABOLISM;
DRUG SAFETY;
DRUG STRUCTURE;
DYSKINESIA;
HUMAN;
MONOTHERAPY;
NEUROPROTECTION;
PARKINSON DISEASE;
SHORT SURVEY;
ANIMALS;
ANTIPARKINSON AGENTS;
HUMANS;
INDANS;
MONOAMINE OXIDASE;
MONOAMINE OXIDASE INHIBITORS;
PARKINSON DISEASE;
|
|
EID: 22244480369
PISSN: 03429601
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (3)
|
|
References (0)
|
